These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23624352)

  • 1. Pullulan-based nanoparticles as carriers for transmucosal protein delivery.
    Dionísio M; Cordeiro C; Remuñán-López C; Seijo B; Rosa da Costa AM; Grenha A
    Eur J Pharm Sci; 2013 Sep; 50(1):102-13. PubMed ID: 23624352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charged pullulan derivatives for the development of nanocarriers by polyelectrolyte complexation.
    Dionísio M; Braz L; Corvo M; Lourenço JP; Grenha A; Rosa da Costa AM
    Int J Biol Macromol; 2016 May; 86():129-38. PubMed ID: 26800902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: Stability and toxicological evaluation.
    Rodrigues S; Cordeiro C; Seijo B; Remuñán-López C; Grenha A
    Carbohydr Polym; 2015 Jun; 123():369-80. PubMed ID: 25843870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
    Shu S; Zhang X; Teng D; Wang Z; Li C
    Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
    Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
    Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.
    de la Fuente M; Seijo B; Alonso MJ
    Macromol Biosci; 2008 May; 8(5):441-50. PubMed ID: 18236434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new chitosan/carrageenan nanoparticles for drug delivery applications.
    Grenha A; Gomes ME; Rodrigues M; Santo VE; Mano JF; Neves NM; Reis RL
    J Biomed Mater Res A; 2010 Mar; 92(4):1265-72. PubMed ID: 19322874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.
    Zhang HZ; Li XM; Gao FP; Liu LR; Zhou ZM; Zhang QQ
    Drug Deliv; 2010 Jan; 17(1):48-57. PubMed ID: 22747075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of stearic acid-pullulan nanoparticles.
    Kim IS; Oh IJ
    Arch Pharm Res; 2010 May; 33(5):761-7. PubMed ID: 20512475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
    Shahbazi MA; Hamidi M; Mohammadi-Samani S
    J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle formation by using shellac and chitosan for a protein delivery system.
    Kraisit P; Limmatvapirat S; Nunthanid J; Sriamornsak P; Luangtana-anan M
    Pharm Dev Technol; 2013; 18(3):686-93. PubMed ID: 22568768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size, Loading Efficiency, and Cytotoxicity of Albumin-Loaded Chitosan Nanoparticles: An Artificial Neural Networks Study.
    Baharifar H; Amani A
    J Pharm Sci; 2017 Jan; 106(1):411-417. PubMed ID: 27866686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and in vivo evaluation of pullulan acetate as a drug nanocarrier.
    Tang HB; Li L; Chen H; Zhou ZM; Chen HL; Li XM; Liu LR; Wang YS; Zhang QQ
    Drug Deliv; 2010; 17(7):552-8. PubMed ID: 20550433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
    Subia B; Kundu SC
    Nanotechnology; 2013 Jan; 24(3):035103. PubMed ID: 23262833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of biotin modified cholesteryl pullulan as a novel anticancer drug carrier.
    Yang W; Wang M; Ma L; Li H; Huang L
    Carbohydr Polym; 2014 Jan; 99():720-7. PubMed ID: 24274563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
    Liu Z; Jiao Y; Liu F; Zhang Z
    J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile.
    Nafee N; Schneider M; Schaefer UF; Lehr CM
    Int J Pharm; 2009 Nov; 381(2):130-9. PubMed ID: 19450671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F; Zhang ZR; Huang Y
    Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.